Cutler Group LP Onconova Therapeutics, Inc. Call Options Transaction History

Cutler Group LP

  • $307 Million
  • Q1 2024

Call Options

2 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2021

Jan 18, 2022
SELL
$2.49 - $3.73 $9,711 - $14,547
-3,900 Closed
0 $0
Q3 2021

Oct 26, 2021
BUY
$3.81 - $6.76 $14,859 - $26,364
3,900 New
3,900 $0

Others Institutions Holding ONTX

# of Institutions
3
Shares Held
249K
Call Options Held
0
Put Options Held
0
View Full List

About Onconova Therapeutics, Inc.

ONTX Quotes by TradingView
  • Ticker ONTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,895,600
  • Market Cap $12.3M
  • Description
  • Onconova Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel products to treat cancer. It has two clinical-stage programs, including narazaciclib (ON 123300), a multi-targeted kinase inhibitor that is in Phase I study for solid tumors, as well as hematological malignancies as a single agent...
More about ONTX
Track This Portfolio

Track Cutler Group LP Portfolio

Follow Cutler Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email